Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Obstet Gynecol

Retrieve available abstracts of 71 articles:
HTML format
Text format



Single Articles


    July 2019

  1. Association of Pharmacist Prescription of Hormonal Contraception With Unintended Pregnancies and Medicaid Costs: Correction.
    Obstet Gynecol. 2019;134:182.
    PubMed     Text format    


    June 2019
  2. SCHWARTZ AR, Russell K, Gray BA
    Approaches to Vaginal Bleeding and Contraceptive Counseling in Transgender and Gender Nonbinary Patients.
    Obstet Gynecol. 2019 Jun 11. doi: 10.1097/AOG.0000000000003308.
    PubMed     Text format     Abstract available


  3. LU CF, Vargas SE, Guillen M, Ramirez JJ, et al
    A Qualitative Study of the Contraceptive Effect on Women's Sexual Experiences: Beyond Hormonal Effects.
    Obstet Gynecol. 2019 Jun 11. doi: 10.1097/AOG.0000000000003331.
    PubMed     Text format     Abstract available



  4. ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions: Correction.
    Obstet Gynecol. 2019;133:1288.
    PubMed     Text format    



  5. ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions: Correction.
    Obstet Gynecol. 2019;133:1288.
    PubMed     Text format    


  6. RODRIGUEZ MI, Hersh A, Anderson LB, Hartung DM, et al
    Association of Pharmacist Prescription of Hormonal Contraception With Unintended Pregnancies and Medicaid Costs.
    Obstet Gynecol. 2019;133:1238-1246.
    PubMed     Text format     Abstract available


  7. ANDERSON L, Hartung DM, Middleton L, Rodriguez MI, et al
    Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid Population.
    Obstet Gynecol. 2019;133:1231-1237.
    PubMed     Text format     Abstract available


    May 2019
  8. RODRIGUEZ MI, Hersh A, Anderson LB, Hartung DM, et al
    Association of Pharmacist Prescription of Hormonal Contraception With Unintended Pregnancies and Medicaid Costs.
    Obstet Gynecol. 2019 May 9. doi: 10.1097/AOG.0000000000003265.
    PubMed     Text format     Abstract available


  9. ANDERSON L, Hartung DM, Middleton L, Rodriguez MI, et al
    Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid Population.
    Obstet Gynecol. 2019 May 9. doi: 10.1097/AOG.0000000000003286.
    PubMed     Text format     Abstract available


    April 2019
  10. RESNIK JL
    What Is New in Contraception?: Best Articles From the Past Year.
    Obstet Gynecol. 2019 Apr 5. doi: 10.1097/AOG.0000000000003237.
    PubMed     Text format     Abstract available


  11. GREENE MZ, Carpenter E, Hendrick CE, Haider S, et al
    Sexual Minority Women's Experiences With Sexual Identity Disclosure in Contraceptive Care.
    Obstet Gynecol. 2019 Apr 5. doi: 10.1097/AOG.0000000000003222.
    PubMed     Text format     Abstract available


    March 2019
  12. COPE AG, Mara KC, Weaver AL, Casey PM, et al
    Postpartum Contraception Usage Among Somali Women in Olmsted County, Minnesota.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003154.
    PubMed     Text format     Abstract available


  13. LAZORWITZ A, Aquilante CL, Oreschak K, Sheeder J, et al
    Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users.
    Obstet Gynecol. 2019 Mar 11. doi: 10.1097/AOG.0000000000003189.
    PubMed     Text format     Abstract available


    February 2019

  14. ACOG Practice Bulletin No. 206: Use of Hormonal Contraception in Women With Coexisting Medical Conditions.
    Obstet Gynecol. 2019;133:e128-e150.
    PubMed     Text format     Abstract available



  15. ACOG Practice Bulletin No. 206 Summary: Use of Hormonal Contraception in Women With Coexisting Medical Conditions.
    Obstet Gynecol. 2019;133:396-399.
    PubMed     Text format     Abstract available


    December 2018
  16. TEAL SB, Turok DK, Chen BA, Kimble T, et al
    Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System.
    Obstet Gynecol. 2018 Dec 4. doi: 10.1097/AOG.0000000000003034.
    PubMed     Text format     Abstract available


  17. ANDERSON S, Frerichs L, Kaysin A, Wheeler SB, et al
    Effects of Two Educational Posters on Contraceptive Knowledge and Intentions: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Dec 4. doi: 10.1097/AOG.0000000000003012.
    PubMed     Text format     Abstract available


    November 2018
  18. GYLLENBERG FK, Saloranta TH, But A, Gissler M, et al
    Induced Abortion in a Population Entitled to Free-of-Charge Long-Acting Reversible Contraception.
    Obstet Gynecol. 2018 Nov 5. doi: 10.1097/AOG.0000000000002966.
    PubMed     Text format     Abstract available


    August 2018
  19. MONTAGUE M, Ascha M, Wilkinson B, Verbus E, et al
    Role of Bridge Contraception in Postpartum Long-Acting Reversible Contraception and Sterilization Fulfillment Rates.
    Obstet Gynecol. 2018 Aug 6. doi: 10.1097/AOG.0000000000002803.
    PubMed     Text format     Abstract available


  20. WU J, Zhang J, Mitra M, Parish SL, et al
    Provision of Moderately and Highly Effective Reversible Contraception to Insured Women With Intellectual and Developmental Disabilities.
    Obstet Gynecol. 2018 Aug 6. doi: 10.1097/AOG.0000000000002777.
    PubMed     Text format     Abstract available


  21. HILLARD PJA
    Contraception for Women With Intellectual and Developmental Disabilities: Reproductive Justice.
    Obstet Gynecol. 2018 Aug 6. doi: 10.1097/AOG.0000000000002814.
    PubMed     Text format    


    July 2018
  22. ROTTENSTREICH A, Bauman D, Kalish Y
    Abnormal Vaginal Bleeding in Women Desiring Contraception Who Are Taking Anticoagulation Therapy.
    Obstet Gynecol. 2018;132:216-217.
    PubMed     Text format    


    May 2018

  23. ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2018;131:e130-e139.
    PubMed     Text format     Abstract available



  24. ACOG Committee Opinion No. 735 Summary: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2018;131:947-948.
    PubMed     Text format     Abstract available


    April 2018
  25. BATRA P, Rafie S, Zhang Z, Singh AV, et al
    An Evaluation of the Implementation of Pharmacist-Prescribed Hormonal Contraceptives in California.
    Obstet Gynecol. 2018 Apr 6. doi: 10.1097/AOG.0000000000002572.
    PubMed     Text format     Abstract available


    March 2018
  26. BONNINGTON A, Autry AM
    Abnormal Vaginal Bleeding in Women Desiring Contraception Who Are Taking Anticoagulation Therapy.
    Obstet Gynecol. 2018 Mar 8. doi: 10.1097/AOG.0000000000002518.
    PubMed     Text format     Abstract available


    February 2018
  27. EVANS ML, Espey E, Ogburn T, Zite NB, et al
    Use of Long-Acting Reversible Contraception by Obstetrics and Gynecology Residents: An Examination of Access for All Women.
    Obstet Gynecol. 2018 Feb 5. doi: 10.1097/AOG.0000000000002489.
    PubMed     Text format     Abstract available


  28. SIMON JA, Catherino W, Segars JH, Blakesley RE, et al
    Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Feb 5. doi: 10.1097/AOG.0000000000002462.
    PubMed     Text format     Abstract available


    January 2018
  29. BRANDI K, Morgan JR, Paasche-Orlow MK, Perkins RB, et al
    Obstetric Outcomes After Failed Hysteroscopic and Laparoscopic Sterilization Procedures.
    Obstet Gynecol. 2018 Jan 9. doi: 10.1097/AOG.0000000000002446.
    PubMed     Text format     Abstract available


  30. STUART GS, Ramesh SS
    Interval Female Sterilization.
    Obstet Gynecol. 2018;131:117-124.
    PubMed     Text format     Abstract available


    December 2017
  31. PAL N, Broaddus RR, Urbauer DL, Balakrishnan N, et al
    Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.
    Obstet Gynecol. 2017 Dec 4. doi: 10.1097/AOG.0000000000002390.
    PubMed     Text format     Abstract available


    November 2017
  32. BIGGS MA, Taylor D, Upadhyay UD
    Role of Insurance Coverage in Contraceptive Use After Abortion.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002361.
    PubMed     Text format     Abstract available


  33. CORTESSIS VK, Barrett M, Brown Wade N, Enebish T, et al
    Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002307.
    PubMed     Text format     Abstract available



  34. Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2017;130:e251-e269.
    PubMed     Text format     Abstract available



  35. Practice Bulletin No. 186 Summary: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Obstet Gynecol. 2017;130:1173-1175.
    PubMed     Text format     Abstract available


    October 2017
  36. MONIZ MH, Gavin LE, Dalton VK
    Performance Measures for Contraceptive Care: A New Tool to Enhance Access to Contraception.
    Obstet Gynecol. 2017 Oct 6. doi: 10.1097/AOG.0000000000002314.
    PubMed     Text format     Abstract available


  37. MENKE MN, King WC, White GE, Gosman GG, et al
    Contraception and Conception After Bariatric Surgery.
    Obstet Gynecol. 2017 Oct 6. doi: 10.1097/AOG.0000000000002323.
    PubMed     Text format     Abstract available


    September 2017
  38. CHEN MJ, Hou MY, Hsia JK, Cansino CD, et al
    Long-Acting Reversible Contraception Initiation With a 2- to 3-Week Compared With a 6-Week Postpartum Visit.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002246.
    PubMed     Text format     Abstract available


  39. MONIZ MH, Spector-Bagdady K, Heisler M, Harris LH, et al
    Inpatient Postpartum Long-Acting Reversible Contraception: Care That Promotes Reproductive Justice.
    Obstet Gynecol. 2017 Sep 5. doi: 10.1097/AOG.0000000000002262.
    PubMed     Text format     Abstract available


    August 2017
  40. ISEYEMI A, Zhao Q, McNicholas C, Peipert JF, et al
    Socioeconomic Status As a Risk Factor for Unintended Pregnancy in the Contraceptive CHOICE Project.
    Obstet Gynecol. 2017 Aug 4. doi: 10.1097/AOG.0000000000002189.
    PubMed     Text format     Abstract available



  41. Committee Opinion No. 710: Counseling Adolescents About Contraception.
    Obstet Gynecol. 2017;130:e74-e80.
    PubMed     Text format     Abstract available



  42. Committee Opinion No. 710 Summary: Counseling Adolescents About Contraception.
    Obstet Gynecol. 2017;130:486-487.
    PubMed     Text format     Abstract available


    July 2017
  43. POTTER JE, Coleman-Minahan K, White K, Powers DA, et al
    Contraception After Delivery Among Publicly Insured Women in Texas: Use Compared With Preference.
    Obstet Gynecol. 2017 Jul 7. doi: 10.1097/AOG.0000000000002136.
    PubMed     Text format     Abstract available



  44. Committee Opinion No 707: Access to Emergency Contraception.
    Obstet Gynecol. 2017;130:e48-e52.
    PubMed     Text format     Abstract available



  45. Committee Opinion No. 707 Summary: Access to Emergency Contraception.
    Obstet Gynecol. 2017;130:251-252.
    PubMed     Text format     Abstract available


    June 2017
  46. KRASHIN JW, Stuart GS, Garrett J, Spector H, et al
    Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002070.
    PubMed     Text format     Abstract available


  47. CARMO LSMP, Braga GC, Ferriani RA, Quintana SM, et al
    Timing of Etonogestrel-Releasing Implants and Growth of Breastfed Infants: A Randomized Controlled Trial.
    Obstet Gynecol. 2017 Jun 6. doi: 10.1097/AOG.0000000000002092.
    PubMed     Text format     Abstract available


  48. MCHUGH KW, Tucker Edmonds B, Ferries-Rowe E, Haas DM, et al
    Implementing Immediate Postpartum Long-Acting Reversible Contraception Programs.
    Obstet Gynecol. 2017;129:1136-1137.
    PubMed     Text format    


    May 2017
  49. MONIZ MH, Chang T, Heisler M, Admon L, et al
    Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the United States, 2008-2013.
    Obstet Gynecol. 2017 May 5. doi: 10.1097/AOG.0000000000001970.
    PubMed     Text format     Abstract available



  50. Committee Opinion No 699: Adolescent Pregnancy, Contraception, and Sexual Activity.
    Obstet Gynecol. 2017;129:e142-e149.
    PubMed     Text format     Abstract available



  51. Committee Opinion No. 699: Adolescent Pregnancy, Contraception, and Sexual Activity.
    Obstet Gynecol. 2017;129:965-966.
    PubMed     Text format     Abstract available


  52. CHESCHEIR NC
    Worldwide Abortion Rates and Access to Contraception.
    Obstet Gynecol. 2017;129:783-785.
    PubMed     Text format    


    April 2017
  53. CHESCHEIR NC
    Worldwide Abortion Rates and Access to Contraception: Speak Up Against the Global Gag Rule.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000002028.
    PubMed     Text format    


  54. ERICKSON AK, Nelson DA, Shaw JG, Loftus PD, et al
    Long-Acting Reversible Contraceptive Placement Among Active-Duty U.S. Army Servicewomen.
    Obstet Gynecol. 2017 Apr 4. doi: 10.1097/AOG.0000000000001971.
    PubMed     Text format     Abstract available



  55. Committee Opinion No. 695: Sterilization of Women: Ethical Issues and Considerations.
    Obstet Gynecol. 2017;129:e109-e116.
    PubMed     Text format     Abstract available



  56. Committee Opinion No 695 Summary: Sterilization of Women: Ethical Issues and Considerations.
    Obstet Gynecol. 2017;129:775-776.
    PubMed     Text format     Abstract available


    March 2017
  57. DARNEY BG, Aiken AR, Kung S
    Access to Contraception in the Context of Zika: Health System Challenges and Responses.
    Obstet Gynecol. 2017 Mar 6. doi: 10.1097/AOG.0000000000001914.
    PubMed     Text format     Abstract available


  58. GOYAL V, Canfield C, Aiken AR, Dermish A, et al
    Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free.
    Obstet Gynecol. 2017 Mar 6. doi: 10.1097/AOG.0000000000001926.
    PubMed     Text format     Abstract available


    February 2017
  59. YANG YT, Sawicki NN
    Pharmacies' Duty to Dispense Emergency Contraception: A Discussion of Religious Liberty.
    Obstet Gynecol. 2017 Feb 6. doi: 10.1097/AOG.0000000000001894.
    PubMed     Text format     Abstract available


    January 2017
  60. WALTER JR, Ghobadi CW, Hayman E, Xu S, et al
    Hysteroscopic Sterilization With Essure: Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance.
    Obstet Gynecol. 2017;129:10-19.
    PubMed     Text format     Abstract available


  61. SCHNATZ PF, Jiang X, Aragaki AK, Nudy M, et al
    Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial.
    Obstet Gynecol. 2017;129:121-129.
    PubMed     Text format     Abstract available



  62. Clinical Updates in Women's Health Care Summary: Liver Disease: Reproductive Considerations.
    Obstet Gynecol. 2017;129:236.
    PubMed     Text format     Abstract available


    December 2016
  63. HOFLER LG, Cordes S, Cwiak CA, Goedken P, et al
    Implementing Immediate Postpartum Long-Acting Reversible Contraception Programs.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  64. HIGGINS JA, Sanders JN, Palta M, Turok DK, et al
    Women's Sexual Function, Satisfaction, and Perceptions After Starting Long-Acting Reversible Contraceptives.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  65. SCOCCIA B
    What Is New in Polycystic Ovary Syndrome?: Best Articles From the Past Year.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


  66. ABBAS DF, Blum J, Ngoc NT, Nga NT, et al
    Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled Trial.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  67. RAYMOND EG, Weaver MA, Louie KS, Tan YL, et al
    Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


    August 2016

  68. Adjunctive Social Media for More Effective Contraceptive Counseling: A Randomized Controlled Trial: Correction.
    Obstet Gynecol. 2016;128:411.
    PubMed     Text format    



  69. Committee Opinion No. 668: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities.
    Obstet Gynecol. 2016;128:e20-5.
    PubMed     Text format     Abstract available



  70. Committee Opinion No. 668 Summary: Menstrual Manipulation for Adolescents With Physical and Developmental Disabilities.
    Obstet Gynecol. 2016;128:418-9.
    PubMed     Text format     Abstract available


    May 2016
  71. MOGLIA ML, Nguyen HV, Chyjek K, Chen KT, et al
    Evaluation of Smartphone Menstrual Cycle Tracking Applications Using an Adapted APPLICATIONS Scoring System.
    Obstet Gynecol. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: